Catalyst Wire Dossier Catalyst Wire Dossier

Treprostinil (oral, monotherapy)

treprostinil · United Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Treprostinil (oral, monotherapy), covering 2013-03-18 to 2013-03-18. Get the full timeline:

Most recent: Clinical Trial Update: FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) [Phase 3]

See pricing